# Par Formulations Private Limited, Chennai, India – FDA Inspections

Source: https://www.keypedia.com/companies/par-formulations-private-limited/f804e8f7-719b-45b4-9aae-3aea30adf070

> Inspection records and compliance data for Par Formulations Private Limited in Chennai. 7 FDA inspections on record, 2 Form 483s, last inspected June 10, 2026.

---

## Details

- Name: Par Formulations Private Limited
- FEI Number: 3007027193
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: 9/215 Pudupakkam-Vandalur Main Road, Pudupakkam, Kelambakkam
- City: Chennai
- Country Name: India
- Address: 9/215 Pudupakkam-Vandalur Main Road, Pudupakkam, Kelambakkam, Chennai, India
- Country: India

## Related Documents

- [483 - Par Formulations Private Limited - 2026-06-10](https://www.keypedia.com/records/483/par-formulations-private-limited/fef7f7a7-e847-416a-b615-2924f0d9ea60) — source: FDA, date: June 10, 2026
- [FDA Inspection 1321302 - Par Formulations Private Limited - 2026-06-10](https://www.keypedia.com/records/fda_inspections/par-formulations-private-limited/a38f8c1a-1d1c-4370-b5f3-109e9180eab1) — source: FDA, date: June 10, 2026
- [FDA Inspection 1205764 - Par Formulations Private Limited - 2023-03-24](https://www.keypedia.com/records/fda_inspections/par-formulations-private-limited/d4aa028e-e5ab-42d0-a606-4f7087a25014) — classification: No Action Indicated (NAI), source: FDA, date: March 24, 2023
- [FDA Inspection 1098295 - Par Formulations Private Limited - 2019-06-21](https://www.keypedia.com/records/fda_inspections/par-formulations-private-limited/319654a7-64af-45fd-8db5-1d83c3aca752) — classification: No Action Indicated (NAI), source: FDA, date: June 21, 2019
- [FDA Inspection 1000693 - Par Formulations Private Limited - 2016-12-07](https://www.keypedia.com/records/fda_inspections/par-formulations-private-limited/68eee17f-7ca7-4bfc-9750-e99cebca3f65) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 7, 2016
- FDA Inspection 927362 - Par Formulations Private Limited - 2015-04-17 — classification: No Action Indicated (NAI), source: FDA, date: April 17, 2015
- FDA Inspection 855562 - Par Formulations Private Limited - 2013-10-17 — classification: No Action Indicated (NAI), source: FDA, date: October 17, 2013
- FDA Inspection 763870 - Par Formulations Private Limited - 2011-09-21 — classification: No Action Indicated (NAI), source: FDA, date: September 21, 2011

## Related Companies

- [Sidmak Laboratories India Pvt Ltd](https://www.keypedia.com/companies/sidmak-laboratories-india-pvt-ltd/2728534a-42a6-48f9-af65-6e6c302663a9)
- [Leading Pharma, LLC](https://www.keypedia.com/companies/leading-pharma-llc/9cbe169a-2e1b-4cdb-848c-209798a79db0)
- [Patheon Softgels Inc.](https://www.keypedia.com/companies/patheon-softgels-inc/10cb6876-0398-4373-a33a-1d1e4c2bcf82)
- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/267a61e8-ff1e-4bcc-b3e3-9248535777f7)
- [ARNA Pharma Pty., Ltd.](https://www.keypedia.com/companies/arna-pharma-pty-ltd/e06145c8-ecf7-4bc1-9e0d-5aab8615b08f)
- [MSN PHARMACEUTICALS INC.](https://www.keypedia.com/companies/msn-pharmaceuticals-inc/9aa0bfdc-4a40-4a82-9bb7-9681dbed726e)
- [CMIC CMO USA Corporation](https://www.keypedia.com/companies/cmic-cmo-usa-corporation/026de3c9-7077-4859-bf21-6304c0c50f29)
- [USAntibiotics LLC](https://www.keypedia.com/companies/usantibiotics-llc/05f8ab3c-a4d5-408f-9314-68ee8aa5e25a)
- [AXXELENT PHARMA SCIENCE PRIVATE LIMITED](https://www.keypedia.com/companies/axxelent-pharma-science-private-limited/0e17ded9-51c9-4db9-9ceb-e39cb2d439db)
- [Cerovene Inc.](https://www.keypedia.com/companies/cerovene-inc/f23e944b-ef46-45b3-8177-af154b404c08)

## Related Officers

- [Yvins Dezan](https://www.keypedia.com/people/yvins-dezan/e9fd12e6-c090-4eb6-bc78-8b80e8a90946)
